Day: September 11, 2025

MONTREAL, Sept. 11, 2025 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) announced today that Glenn J. Chamandy, President & Chief Executive Officer, Luca Barile, Executive Vice-President, Chief Financial Officer and Jessy Hayem, Senior Vice-President, Head of Investor Relations and Global Communications will participate in a fireside chat and one-on-one meetings with investors at the 29th Annual Scotiabank Back to School Conference in Toronto on Wednesday, September 17, 2025. About GildanGildan is a leading manufacturer of everyday basic apparel. The Company’s product offering includes activewear, underwear and socks, sold to a broad range of customers, including wholesale distributors, screenprinters or embellishers, as well as to retailers that sell to consumers through their physical stores and/or e-commerce...

CHICAGO, Sept. 11, 2025 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its wholly owned subsidiary, Sky Pharm SA, signed a distribution agreement (the “Agreement”) with Scientific Pharmacy LLC (“Scientific Pharmacy”) for its Sky Premium Life food supplement products in Oman. Scientific Pharmacy, the retail and wholesale arm of Planet Pharmacies in Oman, is a leading healthcare and beauty company offering integrated distribution and retail services. Known for its international brand partnerships and strong customer focus, it has become a trusted name in Oman and continues to expand across the Gulf Cooperation Council (GCC) region. Planet Pharmacies is owned by Gulf Pharmaceutical Industries (Julphar), based...

Kfar Saba, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the successful completion of a field trial of its DefendAir Stationary Turret system with Israel’s homeland security authority. The trial demonstrated the system’s effectiveness in securing critical infrastructure and sensitive facilities with comprehensive 360-degree perimeter protection, presenting a compelling investment opportunity. The trial was conducted in real-life conditions in Israel and tested the DefendAir turret configuration ability to hostile drones using an advanced optical detection and tracking subsystem. The system achieved 100% interception...

Supports Clinical Development of CLR 121225, Actinium-Labeled Compound for the Treatment of Solid Tumors FLORHAM PARK, N.J. and GARCHING, Germany and MUNICH, Germany, Sept. 11, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (Nasdaq: CLRB, “Cellectar”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, and ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced a supply agreement for Actinium-225 (Ac-225). The agreement will support the clinical development of Cellectar’s actinium-labeled phospholipid ether (PLE) radiopharmaceutical candidates, including its Phase 1-ready compound, CLR 121225, for the treatment of solid tumors. CLR 121225 (225Ac-CLR 121225), a novel actinium-labeled PLE, is under investigation...

WEST PALM BEACH, FL, Sept. 11, 2025 (GLOBE NEWSWIRE) — FOXO Technologies Inc. (OTC: FOXO) (the “Company”), announces that it has signed a stock purchase agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information, data and biospecimen sourcing provider serving the biotechnology, clinical research and pharmaceutical research industries. Vector generated second quarter 2025 net revenues of approximately $225,000 ($0.9 million on an annual run rate basis) and is expected to grow significantly post-acquisition. The expected purchase price consists of: (i) $500,000 in cash, (ii) 60,000 shares of the Company’s Series E Cumulative Redeemable Secured Preferred Stock (the “Series E Preferred Stock”) ($1.5 million in stated value), (iii) warrants to purchase $2 million of the Company’s common stock at a 10% premium to...

According to Entrix, the project’s expansion is projected to boost the project’s revenue, potentially paving the way for higher returns to N2OFF’s stockholders. Neve Yarak, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) — N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, today announced its decision to extend additional debt financing to Solterra Renewable Energy Ltd. (“Solterra”) in connection with its previously reported Melz solar project for the purpose of integrating a large-scale battery energy storage system (BESS) into its 115 MWp solar photovoltaic project in Melz, Germany. The planned “green” BESS will have a capacity of 107 MW / 214 MWh and is designed to optimize electricity sales while providing additional grid services...